Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0297-2021

Drug recall · March 10, 2021

Metoclopramide Injection USP recall

Why: Chemical contamination; Unknown brown residue adhering to the inside of one vial.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)

Lots / codes

Lot # 31325335B, exp. date 07/2021

Quantity
9,452 cartons
Company
Teva Pharmaceuticals USA, Parsippany, NJ
Distribution
Nationwide, including Puerto Rico
Initiated
February 15, 2021 · Voluntary: Firm initiated
Classified
March 3, 2021
Reported
March 10, 2021
Ended
August 26, 2021
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Metoclopramide

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.